White blood cells, neutrophils, and reactive oxygen metabolites among asymptomatic subjects

International Journal of Preventive Medicine

Volumn 3, Issue 6, 2012, Pages 428-431

  Kotani, Kazuhiko ^a,b   Sakane, Naoki ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

C reactive protein; Inflammation; Leukocyte; Neutrophil; Oxidative stress

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; BODY MASS; CARDIOVASCULAR RISK; CELL POPULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LEUKOCYTE; NEUTROPHIL COUNT; OXIDATIVE STRESS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

EID: 84863487176     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: An overview. Free Radic Biol Med 2000;28:1815-26.
2. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
3. Kotani K, Taniguchi N. Correlation between high-sensitivity C-reactive protein and reactive oxygen metabolites during a one-year period among asymptomatic subjects. J Clin Med Res 2012;4:52-5.
4. Stephens JW, Khanolkar MP, Bain SC. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 2009;202:321-9.
5. Hoffman M, Blum A, Baruch R, Kaplan E, Benjamin M. Leukocytes and coronary heart disease. Atherosclerosis 2004;172:1-6.
6. Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: A systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:483-95.
7. Stuart J, George AJ, Davies AJ, Aukland A, Hurlow RA. Haematological stress syndrome in atherosclerosis. J Clin Pathol 1981;34:464-7.
8. Helfand M, Buckley DI, Freeman M, Fu R, Rogers K, Fleming C, et al. Emerging risk factors for coronary heart disease: A summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:496-507.
9. Harlan JM, Killen PD, Harker LA, Striker GE, Wright DG. Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. J Clin Invest 1981;68:1394-403.
10. Görög P. Neutrophil-oxidized low density lipoprotein: Generation in and clearance from the plasma. Int J Exp Pathol 1992;73:485-90.
11. Cooper HA, Exner DV, Waclawiw MA, Domanski MJ. White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction [SOLVD]). Am J Cardiol 1999;84:252-7.
12. Gurm HS, Bhatt DL, Lincoff AM, Tcheng JE, Kereiakes DJ, Kleiman NS, et al. Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: Insights from the EPIC, EPILOG, and EPISTENT trials. Heart 2003;89:1200-4.
13. Kinnula VL, Ilumets H, Myllärniemi M, Sovijärvi A, Rytilä P. 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD. Eur Respir J 2007;29:51-5.
14. Cheng ML, Chen CM, Gu PW, Ho HY, Chiu DT. Elevated levels of myeloperoxidase, white blood cell count and 3-chlorotyrosine in Taiwanese patients with acute myocardial infarction. Clin Biochem 2008;41:554-60.
15. Flegar-Mestrić Z, Nazor A, Jagarinec N. Haematological profile in healthy urban population (8 to 70 years of age). Coll Antropol 2000;24:185-96.
16. Kasama T, Miwa Y, Isozaki T, Odai T, Adachi M, Kunkel SL. Neutrophil-derived cytokines: Potential therapeutic targets in inflammation. Curr Drug Targets Inflamm Allergy 2005;4:273-9.
17. Jala VR, Haribabu B. Leukotrienes and atherosclerosis: New roles for old mediators. Trends Immunol 2004;25:315-22.
18. Kokura S, Yoshida N, Yoshikawa T. Anoxia/reoxygenation-induced leukocyte-endothelial cell interactions. Free Radic Biol Med 2002;33:427-32.